VH family usage in IGH rearrangements in multiple myeloma
| . | VH1, no. (%) . | VH2, no. (%) . | VH3, no. (%) . | VH4, no. (%) . | VH5, no. (%) . | VH6, no. (%) . | No. of patients . |
|---|---|---|---|---|---|---|---|
| Baker et al, 199445 | 5 (17.9) | 1 (3.6) | 15 (53.6) | 6 (21.4) | 0 (0) | 1 (3.6) | 28 |
| Rettig et al, 199618 | 13 (18.1) | 4 (5.6) | 34 (47.2) | 14 (19.4) | 6 (8.3) | 1 (1.4) | 72 |
| Kiyoi et al, 199619 | 4 (17.4) | 1 (4.3) | 10 (43.5) | 4 (17.4) | 4 (17.4) | 0 (0.0) | 23 |
| Gonzalez et al, 200520 | 6 (8.2) | 5 (6.8) | 42 (57.5) | 15 (20.6) | 5 (6.8) | 0 (0.0) | 73 |
| Hadzidimitriou et al, 200646 | 14 (18.9) | 6 (8.1) | 31 (41.9) | 16 (21.6) | 6 (8.1) | 1 (1.4) | 74 |
| Total | 42 (15.6) | 17 (6.3) | 132 (48.9) | 55 (20.4) | 21 (7.8) | 3 (1.1) | 270 |
| . | VH1, no. (%) . | VH2, no. (%) . | VH3, no. (%) . | VH4, no. (%) . | VH5, no. (%) . | VH6, no. (%) . | No. of patients . |
|---|---|---|---|---|---|---|---|
| Baker et al, 199445 | 5 (17.9) | 1 (3.6) | 15 (53.6) | 6 (21.4) | 0 (0) | 1 (3.6) | 28 |
| Rettig et al, 199618 | 13 (18.1) | 4 (5.6) | 34 (47.2) | 14 (19.4) | 6 (8.3) | 1 (1.4) | 72 |
| Kiyoi et al, 199619 | 4 (17.4) | 1 (4.3) | 10 (43.5) | 4 (17.4) | 4 (17.4) | 0 (0.0) | 23 |
| Gonzalez et al, 200520 | 6 (8.2) | 5 (6.8) | 42 (57.5) | 15 (20.6) | 5 (6.8) | 0 (0.0) | 73 |
| Hadzidimitriou et al, 200646 | 14 (18.9) | 6 (8.1) | 31 (41.9) | 16 (21.6) | 6 (8.1) | 1 (1.4) | 74 |
| Total | 42 (15.6) | 17 (6.3) | 132 (48.9) | 55 (20.4) | 21 (7.8) | 3 (1.1) | 270 |